132 related articles for article (PubMed ID: 11531139)
1. Prognostic significance of nuclear morphometry in superficial bladder cancer.
Ozer E; Yörükoğlu K; Mungan MU; Ozkal S; Demirel D; Sağol O; Kirkali Z
Anal Quant Cytol Histol; 2001 Aug; 23(4):251-6. PubMed ID: 11531139
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
3. [Usefulness of nuclear morphometry as predictive factor of progression in bladder papillary carcinoma].
García I; Alvarez M; Hierro I; Vicioso L; Hidalgo R; Matilla A
Actas Urol Esp; 1994; 18(10):937-41. PubMed ID: 7856480
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of morphometry in low grade papillary urothelial bladder neoplasms.
Ramos D; Ruiz A; Morell L; Navarro S; Villamón R; Gil-Salom M; Llombart-Bosch A
Anal Quant Cytol Histol; 2004 Oct; 26(5):285-94. PubMed ID: 15560535
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of nuclear morphometry in renal cell carcinoma.
Ozer E; Yörükoğlu K; Sagol O; Mungan U; Demirel D; Tüzel E; Kirkali Z
BJU Int; 2002 Jul; 90(1):20-5. PubMed ID: 12081763
[TBL] [Abstract][Full Text] [Related]
6. Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas.
Krüger S; Müller H
Br J Urol; 1995 Apr; 75(4):480-4. PubMed ID: 7788260
[TBL] [Abstract][Full Text] [Related]
7. [Clinical prognostic factors in superficial cancer of the urinary bladder].
Busto Catañón L; Sánchez Merino JM; Picallo Sánchez JA; Gelabert Mas A
Arch Esp Urol; 2001 Mar; 54(2):131-8. PubMed ID: 11341116
[TBL] [Abstract][Full Text] [Related]
8. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder.
Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A
Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659
[TBL] [Abstract][Full Text] [Related]
9. Expression of pS2 protein and its relation with the Ki-67 proliferative indices and tumor recurrence in superficial bladder carcinomas.
Sagol O; Yörükoglu K; Tuna B; Ozer E; Sis B; Güray M; Mungan U; Kirkali Z
Eur Urol; 2001 Aug; 40(2):163-8. PubMed ID: 11528193
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder.
Popov Z; Hoznek A; Colombel M; Bastuji-Garin S; Lefrere-Belda MA; Bellot J; Abboh CC; Mazerolles C; Chopin DK
Cancer; 1997 Oct; 80(8):1472-81. PubMed ID: 9338472
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
12. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
[TBL] [Abstract][Full Text] [Related]
13. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F
J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
[TBL] [Abstract][Full Text] [Related]
14. Nuclear morphometry for improved prediction of the prognosis of human bladder carcinoma.
Fukuzawa S; Hashimura T; Sasaki M; Yamabe H; Yoshida O
Cancer; 1995 Nov; 76(10):1790-6. PubMed ID: 8625049
[TBL] [Abstract][Full Text] [Related]
15. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
Bertz S; Otto W; Denzinger S; Wieland WF; Burger M; Stöhr R; Link S; Hofstädter F; Hartmann A
Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
[TBL] [Abstract][Full Text] [Related]
16. Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC.
Ding W; Gou Y; Sun C; Xia G; Wang H; Chen Z; Tan J; Xu K; Qiang D
Urol Oncol; 2014 Jan; 32(1):42.e13-9. PubMed ID: 24360660
[TBL] [Abstract][Full Text] [Related]
17. p53 protein expression and proliferative activity in imprints of superficial transitional cell carcinoma of the bladder.
Ioakim-Liossi A; Pantazopoulos D; Karakitsos P; Athanassiadou P; Aroni K; Giahnaki AE; Athanassiades P
Anal Quant Cytol Histol; 2000 Jun; 22(3):223-8. PubMed ID: 10872039
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of proliferative activity and nuclear morphometry for progression in TaT1 urothelial cell carcinomas of the urinary bladder.
Bol MG; Baak JP; Rep S; Marx WL; Kruse AJ; Bos SD; Kisman O; Voorhorst FJ
Urology; 2002 Dec; 60(6):1124-30. PubMed ID: 12475695
[TBL] [Abstract][Full Text] [Related]
19. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
Popov Z; Gil-Diez-De-Medina S; Ravery V; Hoznek A; Bastuji-Garin S; Lefrere-Belda MA; Abbou CC; Chopin DK
Urol Oncol; 2004; 22(2):93-101. PubMed ID: 15082004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
